Clinical Trials Directory

Trials / Completed

CompletedNCT05397353

Sleep Treatment for Teens

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Rutgers, The State University of New Jersey · Academic / Other
Sex
All
Age
14 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research study is to test a brief (6-session), empirically supported, and highly disseminable version of digital (i.e., smartphone or web-based) cognitive behavioral therapy for insomnia (dCBT-I), called SleepioTM, in suicidal adolescents with co-occurring insomnia during the high-risk post-hospitalization period. Suicide is the 2nd leading cause of death among adolescents. Sleep problems, such as insomnia symptoms-the most common sleep problem in youth-may be a particularly promising treatment target to reduce suicide risk in adolescents. The investigators propose to test the feasibility, acceptability, and effectiveness of dCBT-I in a two-site (Rutgers and Old Dominion University) pilot study trial. Adolescents, 14-18 years-old, recently hospitalized for suicide risk with co-occurring insomnia (n=20 pilot, 50% at each site), will receive dCBT-I (six weekly, 20-minute sessions) plus post-hospitalization treatment-as-usual (TAU). Adolescents will complete assessments pre-treatment, during the treatment phase including at the end of treatment, and 1-month follow-up post-treatment.

Conditions

Interventions

TypeNameDescription
OTHERSleepio (TM)Sleepio is a mobile Digital Cognitive Behavior Therapy for Insomnia (dCBT-I) app.

Timeline

Start date
2023-02-10
Primary completion
2025-01-24
Completion
2025-04-04
First posted
2022-05-31
Last updated
2025-06-13

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05397353. Inclusion in this directory is not an endorsement.